Stockreport

Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR [Yahoo! Finance]

Glaukos Corporation  (GKOS) 
Last glaukos corporation earnings: 2/27 04:15 pm Check Earnings Report
PDF on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved [Read more]